Induction Healthcare Group

(INHC)
Sector: Medical Equipment and Services
7.50p
0.00p 0.00
Last updated: 16:57:05

1 day chart

6 month chart

DIY Investing
Hargreaves Lansdown - Improve the way you pick shares

Today's buy and sell prices

The price at which you can buy a share or investment. It is usually higher than the bid (sell) price. It’s the price you are being offered. Offer 10.00p
The price at which you can sell a share or investment. It is lower than the offer (buy) price. Bid 7.00p
The difference between the bid and offer prices expressed as a percentage. When you buy shares you pay a higher price than you get when you sell them. The difference between these prices is the profit made by the market maker who puts the deals together. Spread 30.00

Today's trading

Range The lowest and the highest price a share has reached in the trading day. 7.15p-7.50p
The lowest and the highest price a share has reached in the trading day. Volume 48,543.00
The lowest and the highest price a share has reached in the trading day. Today's open 7.50p
At the end of the trading day there is an official closing price for every share. The previous session’s close is used as the base to calculate the following day’s price changes. Previous close 7.50p

Yearly summary

The highest and lowest prices the shares have traded at over a rolling 52-week period. It gives you a good indication of how the share price is performing now relative to its recent past performance. 52wk range 7.15p-28.40p

Fundamentals and health

A measure of the company's worth on the stock market. We display the previous closing share price multiplied by the number of shares in issue. Market capitalisation £6.93
The number of shares a company has in circulation, in millions. Shares in issue 92.38
The main valuation used by investors and a way of gauging whether a company's share price is cheap or expensive compared to competitors. You get PE by dividing the share price by the earnings per share (EPS). Our figure is last basic unadjusted - reported - annual EPS / current share price x 100. Companies also quote adjusted EPS figures to remove the effect of one-off exceptional figures from the profit figures. There is debate among investors as to whether this should be used. We use basic EPS – the purest figure. PE ratio n/a
PEG ratio n/a
An important ratio for showing how much profit after tax and other deductions (net profit) is actually being earned per share. You divide the net profit by the number of shares in issue. Expressed in pence per share. Looking at whether the EPS is rising or falling over time is one of the most important indicators of whether a company is really making money for its shareholders. Our figure is undiluted, meaning it is not adjusted for exceptional costs. EPS -18.00p
Earnings per share growth illustrates the growth of earning per share over the last two reporting periods. It helps investors identify stocks that are increasing or decreasing in profitability. A minus sign indicates negative growth. EPS growth n/a
Return on capital employed measures a company's profitability in relation to how much capital is invested in the business. Generally, the higher the figure the better but with all these ratios it is best to compare companies from the same sector. A high double digit figure may mean a company has an advantage over its competitors because of a unique product but an oil company, for example, will have higher capital outlay than an online retailer. Our formula: [Pre-tax profit / (total assets – short-term liabilities)] * 100 ROCE -779.37
Also known as the acid test ratio, it's a quick guide to how well a company can pay its short-term debts. Above 1 is considered healthy. A ratio of 1.5 would mean the company has £1.50 of liquid (accessible) assets to cover each £1 of debt (current liabilities). Formula: Current assets minus inventory / current liabilities. Quick ratio n/a
Indicates whether a company can convert assets into cash to pay its debts within the next 12 months. It is calculated as current assets / current liabilities for the same period but will display as '0' for companies such as banks that don't distinguish between short and long-term liabilities. Current ratio 1.81
The amount of money a company paid to a shareholder for each share they own over the past 12 months, expressed in pence. Total dividends per share n/a
The dividends paid per share over the past 12 months (interim plus final) as a percentage of the share price. Our figure includes recurring special dividends. Dividend yield n/a
The number of times the dividend could have been paid out from net profits. It is a good indicator of the company's ability to pay the dividend and its level of generosity. Formula: earnings per share / dividends per share. More than 2 is considered healthy, less than 1.5 may hint that a dividend is at risk of being cut. Dividend cover n/a
Dividend per share growth n/a

Induction Healthcare Group Fundamentals

Induction Healthcare Group PLC is a healthcare technology company focused on streamlining the delivery of care by Healthcare Professionals. The Group's technology helps Healthcare Professionals to save time and deliver care more effectively and Healthcare Institutions to identify ways to allocate resources more efficiently.

Induction Healthcare Group Regulatory news

Date Time Headline Source
13/08/2024 13:29 Result of AGM RNS
29/07/2024 10:00 Block Listing Six Monthly Return RNS
17/07/2024 07:00 Grant of Options RNS
04/07/2024 07:00 Final Results RNS
01/07/2024 11:07 AMENDMENT: DIVESTMENT OF HORIZON RNS
01/07/2024 07:00 DIVESTMENT OF HORIZON STRATEGIC PARTNERS LIMITED RNS
27/06/2024 07:00 Publication of Full Year Financial Results Delayed RNS
29/04/2024 07:00 Full Year Trading Update RNS
29/01/2024 07:00 Block listing Interim Review RNS
07/11/2023 07:00 Half-year Report RNS

Induction Healthcare Group Latest trades

Latest trades

Date Time Price Amount Value Type Buy / sell
19/09/2024 08:01:02 7p 48,543 £3,398.01 O Sell

Analysis

Buy Sell
Quantity 0 1
Volume 0 48,543
Value £0 £3,471

Induction Healthcare Group Director dealings

Trade date Director Volume / Price Trade value Trade type
13/01/2023 Christopher Samler 266,667 @ 22.50p £60,000.08 Buy
12/04/2022 Andrew Williams 179,484 @ 51.50p £92,434.26 Buy
11/04/2022 Andrew Williams 190,989 @ 52.50p £100,269.23 Buy
11/04/2022 Leslie-Ann Reed 57,100 @ 52.50p £29,977.50 Buy
11/04/2022 Dimitrie Spiru Hugo Stephenson 100,000 @ 54.10p £54,100.00 Buy
11/04/2022 Guy Mitchell 9,200 @ 54.10p £4,977.20 Buy
11/04/2022 James Balmain 7,300 @ 54.10p £3,949.30 Buy
02/12/2021 Dimitrie Spiru Hugo Stephenson 30,000 @ 48.00p £14,400.00 Buy
02/12/2021 Andrew Williams 100,000 @ 48.00p £48,000.00 Buy
26/06/2019 Jane Elizabeth Silber 0 @ 0.00 0.00 Notification of Holding

Induction Healthcare Group Broker views

Date Broker Recomm. Old target price New target price Notes
07/06/2022 Canaccord Genuity buy - 80.00p new coverage

Induction Healthcare Group News

Stockopedia: Comprehensive stock market insights